Response to: Correspondence on 'EULAR recommendations for the management of ANCA-associated vasculitis: 2022 update' by Hellmich <i>et al</i>.

Hellmich, Bernhard; Jayne, David

Response to: Correspondence on 'EULAR recommendations for the management of ANCA-associated vasculitis: 2022 update' by Hellmich et al.

Hellmich, Bernhard; Jayne, David.

Afiliação

Hellmich B; Department of Internal Medicine, Rheumatology, Pulmonology, Nephrology and Diabetology, Medius Kliniken, University of Tübingen, Kirchheim-Teck, Germany b.hellmich@medius-kliniken.de.
Jayne D; Division of Nephrology, Addenbrooke's Hospital, Cambridge, UK.

Ann Rheum Dis ; 2024 Apr 03.

Article em En | MEDLINE | ID: mdl-38569852

Palavras-chave

Patient Reported Outcome Measures; Systemic vasculitis; Therapeutics

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Ann Rheum Dis Ano de publicação: 2024 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Ann Rheum Dis Ano de publicação: 2024 Tipo de documento: Article